Illustration of the human brain with DNA strands in the background, depicting the concept of MSA genetic factors.

When you or a loved one receives a diagnosis of Multiple System Atrophy (MSA), one of the first questions that often comes up is: “Is MSA genetic?” or “Could my children or siblings get it too?” In this article, we’ll explore the complex topic of MSA and heredity. We’ll look at the question of is MSA hereditary, outline what we currently know about the multiple system atrophy causes, examine evidence on MSA and family history, and explain the concept of genetic risk of MSA in simple, easy-to-understand terms.

Our goal is to give you clear, authoritative information so you and your family can make better-informed decisions and ask the right questions of the healthcare team.

What is MSA and Why Genetics Matter

Before diving into heredity, let’s briefly recap what MSA is.

  • MSA is a rare, progressive neurological disorder that affects multiple parts of the brain and nervous system, including movement, balance, coordination, and the autonomic system (which controls blood pressure, bladder, bowel, sweat).
  • There are two main types: MSA-P (parkinsonian type) and MSA-C (cerebellar type).
  • Because the condition involves many systems and progresses relatively quickly, it causes understandable concern about what caused it including whether it runs in families.

So when we ask “Is MSA genetic?” we’re really asking:

  • Does inheritance (passing from parent to child) play a significant role?
  • If I have the condition, does that mean my relatives are at higher risk?
  • Are there identifiable gene changes that clearly cause MSA?

Learn More About Is MSA the Same as Parkinson’s Disease? How to Tell Them Apart

What Do We Know About the Causes of MSA

Understanding the multiple system atrophy causes helps frame where genetics fit in and where they don’t.

Key points on causes

  • The exact cause of MSA remains unknown.
  • Research suggests that both genetic and environmental factors may play a role, but no single cause has been identified.
  • Some of the suspected mechanisms include abnormal accumulation of the protein alpha-synuclein in certain brain cells, mitochondrial dysfunction, oxidative stress and other cell-damage pathways.

Where genetics enters the picture

  • Studies have shown that certain gene variants (for example in the SNCA gene, which also has relevance in other neurodegenerative diseases) may modestly increase risk of MSA.
  • More recently, large genome-wide association studies (GWAS) have identified new risk loci linked to MSA in people of European ancestry.
  • However: these are risk modifiers, not fixed inherited causes. Many cases of MSA remain truly sporadic (no family history).

In short: genetics may influence who is more likely to develop MSA, but they do not explain most cases by themselves.

Learn More About PSP Life Expectancy : Managing Symptoms and Enhancing Quality of Life

Is MSA Hereditary? What the Research Shows

This is the central question: is MSA hereditary meaning passed directly from parent to child in a predictable pattern.

What’s the evidence

  • According to the U.S. government genetic reference site MedlinePlus: “Most cases of MSA are sporadic, which means they occur in people with no history of the disorder in their family.”
  • Yet, there are rare reports of families where more than one person developed MSA suggesting a possible hereditary component in very few cases.
  • A recent review titled “The genetic basis of multiple system atrophy” estimates the pooled heritability (the proportion of variation due to genes) at about 2.09-6.65%.

What this means in practice

  • For the vast majority of people with MSA, there is no obvious family history, and the chance that a sibling or child will develop MSA because a relative has it is very low.
  • In rare families, there may be a higher risk (though still small) because of shared genetic or environmental risk factors but this is not the norm.
  • Because the condition is so rare and because most cases appear to be sporadic, population-based risk remains very low even among relatives.

Hereditary risk of MSA

ScenarioDescriptionRelative risk to family members
Typical sporadic MSA caseNo family history, gene variants uncertainVery low risk for siblings / children
Rare familial-clustering caseTwo or more family members affected across generationsSlightly elevated risk, but still low overall
Known risk gene variantIdentified in research gene studyNot routinely used in clinical risk prediction

Learn More About Follow-Up Care in Wilson’s Disease: Tracking Copper Levels and Progress

What Role Does Family History and Genetic Risk of MSA Play?

Let’s talk about family history and MSA risk and how to interpret “genetic risk of MSA” realistically.

Key things to know

  • Having a first-degree relative (parent, sibling, child) with MSA does not guarantee you will develop MSA the risk remains low.
  • Because the underlying gene variants that may influence MSA risk are small-effect and not yet clinically actionable, genetic testing is not standard for MSA at this time.
  • Environmental and lifestyle influences may interact with genetic susceptibility so two relatives with the same gene variant might not develop MSA if other influences differ.

Practical implications for families

  • If a person with MSA asks: “What about my kids?” the correct message is: while you should remain alert to movement or autonomic symptoms and maintain regular health check-ups, there is no strong evidence that family members must expect MSA simply because one person has it.
  • Genetic counselling may be considered in very rare cases of family-clustering, but this is not the routine scenario.
  • A history of other movement disorders in the family (like Parkinson’s) may raise questions but the connection between those and MSA is not clear or strong in terms of direct inheritance.

Learn More About Living Better with Huntington’s: Life Expectancy and Quality of Care

Why the Confusion? Why Do People Assume MSA May Be Genetic?

Several factors contribute to confusion around this topic.

Why the uncertainty arises

  • MSA shares symptoms with other conditions (for example Parkinson’s Disease) that do sometimes have genetic components.
  • The word “syndrome” and the “multiple system” label may imply broad systemic causes, including genetic ones which can sound alarming.
  • When two or more family members develop a rare disorder, people naturally look for a hereditary explanation and some small studies have found such clusters.
  • The science of gene-environment interactions is newer and complex, so media coverage may simplify it into “genetic = inherited”.

Why it’s helpful to clarify

  • Understanding that most cases are not clearly inherited reduces unnecessary anxiety for relatives.
  • It helps families focus energy and resources where it matters most monitoring symptoms, accessing early specialist care, managing autonomic or movement effects rather than worrying unduly about genetic fate.
  • It permits realistic discussions with neurologists rather than assuming “inherited” and making decisions based on that assumption.

Learn More About Juvenile Huntington’s: Understanding the Childhood Form

Should You Get Genetic Testing or Counselling?

If you’re reading this and wondering about your own or your family’s risk, the question of genetic testing arises.

When genetic testing might be considered

  • When there is strong family history (two or more first-degree relatives with MSA or a closely related disorder) and the neurologist or geneticist suggests it.
  • When research protocols or trials are available (in selected centres) that study gene variants in MSA.
  • But at present, there is no clinically validated test that predicts MSA in unaffected individuals with high certainty.

What to ask your neurologist

  • “Given my family history / my case, what is my realistic risk for relatives or children?”
  • “Are there any gene variants known in my case or being studied?”
  • “Would genetic counselling be appropriate in our situation?”
  • “What lifestyle, environmental or monitoring steps can we take nonetheless?”

Frequently Asked Questions (FAQ)

1. Is MSA hereditary?

In most cases, MSA is not hereditary. Research shows that the condition usually occurs sporadically, meaning it appears in someone with no family history of the disease. Only very rare families have more than one affected member.

2. Does having MSA increase the risk for my children or siblings?

The risk is very low. Even though a few genetic risk factors have been studied, they do not act like classic inherited genes. So, simply having a family member with MSA does not strongly increase your chance of developing it.

3. Should I undergo genetic testing for MSA?

Routine genetic testing is not recommended, because no definitive “MSA gene” has been identified. Testing may be discussed only in rare cases where two or more close relatives have similar symptoms.

4. Does family history mean I will get MSA?

Not necessarily. MSA and family history are loosely connected in research, but not in a way that predicts the disease. Most people with a family member who has MSA never develop the condition.

5. How can I reduce my risk of MSA?

Because the genetic risk of MSA is low and specific causes are still unclear, there is no guaranteed prevention. However, maintaining overall neurological health staying active, managing blood pressure, eating healthy, and avoiding harmful toxins is generally helpful.

Conclusion

Understanding whether MSA is genetic can bring clarity and peace of mind to families who are already dealing with the challenges of Multiple System Atrophy. Current scientific evidence strongly shows that most cases are not hereditary, and the chances of passing MSA directly from parent to child are very low. While certain gene variations may slightly influence susceptibility, they do not guarantee the disease, nor do they follow a predictable pattern of inheritance.

What truly matters is early recognition, timely symptom management, and supportive care. Focusing on the person’s daily quality of life rather than worrying about genetic destiny empowers families to take practical steps that make a real difference.

If you or someone in your family is navigating an MSA diagnosis, seeking guidance from the best neurologist in Ahmedabad can ensure accurate information, personalized care, and long-term support tailored to the patient’s unique needs. With the right medical partner and clear understanding, families can approach MSA with confidence, compassion, and hope.

Authoritative References

Share the Post:

Related Posts

Trusted Neurologist & Fellowship-Trained Movement Disorder Specialist

Dr. Mitesh Chandarana

Dr. Mitesh Chandarana is a highly experienced neurologist, specializing in Parkinson’s disease and movement disorders. With over 10 years of experience in neurology and 5+ years dedicated to movement disorders, he combines deep clinical knowledge with advanced treatment approaches like Botulinum Toxin Therapy and Deep Brain Stimulation (DBS).

He completed his prestigious Post-Doctoral Fellowship in Movement Disorders from Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum — one of India’s most renowned neurological institutes.

Read More >>>

“Every patient deserves accurate diagnosis, advanced care, and hope. My goal is to bring that to every consultation.”